日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 科研級生物類似抗體
  4. TNFSF13 (JADE-001 Biosimilar) Recombinant Monoclonal Antibody

TNFSF13 (JADE-001 Biosimilar) Recombinant Monoclonal Antibody

  • 貨號：
    CSB-RA023989MB1HU
  • 規(guī)格：
    ￥83486
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    TNFSF13 (JADE-001 Biosimilar Antibody)重組單克隆抗體是一種針對腫瘤壞死因子超家族成員13（TNFSF13）的生物制劑，主要用于生命科學(xué)研究領(lǐng)域。該抗體通過重組DNA技術(shù)在哺乳動(dòng)物細(xì)胞中表達(dá)，具有高純度、高特異性和批次間一致性的特點(diǎn)，為研究TNFSF13的生物學(xué)功能及其在疾病發(fā)生發(fā)展中的作用提供了可靠工具。 TNFSF13作為重要的免疫調(diào)節(jié)因子，在B淋巴細(xì)胞的存活、增殖與分化中發(fā)揮關(guān)鍵作用，同時(shí)與自身免疫性疾病、腫瘤等多種病理過程密切相關(guān)。本產(chǎn)品可通過特異性結(jié)合TNFSF13，有效阻斷其與受體的相互作用，從而助力研究該因子在免疫調(diào)控網(wǎng)絡(luò)中的分子機(jī)制。 該抗體經(jīng)過嚴(yán)格的質(zhì)量控制，包括SDS-PAGE純度分析、ELISA效價(jià)測定及功能性驗(yàn)證，確保在實(shí)驗(yàn)中展現(xiàn)穩(wěn)定的結(jié)合活性和生物效應(yīng)。適用于多種實(shí)驗(yàn)技術(shù)，如及細(xì)胞功能測定等，為探索TNFSF13相關(guān)信號通路、開發(fā)靶向治療策略等基礎(chǔ)研究提供有力支持。 作為科研級試劑，本產(chǎn)品僅供實(shí)驗(yàn)室研究使用，不用于臨床診斷或治療。其研發(fā)旨在推動(dòng)免疫學(xué)、細(xì)胞生物學(xué)及相關(guān)領(lǐng)域的科學(xué)探索，為深入理解TNFSF13的生理與病理意義提供高質(zhì)量的實(shí)驗(yàn)材料。
  • Uniprot No.：
  • 基因名：
  • 別名：
    JADE001 research-grade biosimilar; JADE 001 research-grade biosimilar; JADE101 research-grade biosimilar; PR030 research-grade biosimilar; PR 030 research-grade biosimilar; PR-030 research-grade biosimilar ;TNFSF13 antibody; APRIL antibody; TALL2 antibody; ZTNF2 antibody; UNQ383/PRO715 antibody; Tumor necrosis factor ligand superfamily member 13 antibody; A proliferation-inducing ligand antibody; APRIL antibody; TNF- and APOL-related leukocyte expressed ligand 2 antibody; TALL-2 antibody; TNF-related death ligand 1 antibody; TRDL-1 antibody; CD antigen CD256 antibody
  • 反應(yīng)種屬：
    Human
  • 免疫原：
    Recombinant Human TNFSF13 protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標(biāo)記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    0.01M PBS，pH7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應(yīng)用說明：
    Validation Status
    Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
    Guaranteed Quality
    ① Antibody purity?> 95% tested by SDS-PAGE.
    ② Endotoxin level < 0.1EU/ug tested by LAL method.
  • 儲(chǔ)存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    3-4 weeks
  • 用途：
    It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

  • 功能：
    Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. Plays a role in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes.
  • 基因功能參考文獻(xiàn)：
    1. TNFSF13, SPATC1L, SLC22A25 and SALL4 may thus be novel susceptibility loci for atrial fibrillation in the Japanese population PMID: 28849223
    2. The results suggest that increased levels of BAFF and APRIL produced in the central nervous system may influence the development of anti-neutrophil cytoplasmic antibody-hypertrophic pachymeningitis. PMID: 28847534
    3. The genetic variations and gene expression level of TNFSF13 are associated with the susceptibility and severity of IgA nephropathy in a Han Chinese population. PMID: 28636766
    4. APRIL levels are associated with disease activity in human chronic graft-versus-host disease. PMID: 26992945
    5. APRIL but not BLyS promotes IL-10 production by CpG-activated B cells and enhances the regulatory role of B cells on T cells. PMID: 27372914
    6. BCMA has other contributors for ligands binding except DxL motif. The affinity of BCMA for APRIL higher than for BAFF may be caused by the segment outside of the conservative DxL motif. Moreover, the exposition of new binding modes of BCMA2 interacting with APRIL may establish the foundation of designing novel drugs in the future PMID: 28260502
    7. APRIL transgenic mice infected by Helicobacter species may represent a novel animal model of gastric lymphomagenesis. PMID: 28460208
    8. ApoE-/-APRIL-Tg mice have increased oxLDL-specific serum IgM levels, potentially mediated via an increase in B1a lymphocytes PMID: 27820817
    9. Results showed that chemokine-mediated recruitment of neutrophils secreting the tumor-promoting factor APRIL mediates DLBCL progression. PMID: 27923834
    10. This study showed that both BAFF and APRIL levels were increased in CSF of patients with anti-NMDAR encephalitis. PMID: 28284352
    11. The results demonstrated that rs11552708 of the APRIL gene is not associated with Systemic lupus erythematosus (SLE) susceptibility in Iranian children. Likewise, these findings suggest that APRIL antagonist could be a potential therapeutic target to control SLE in children. PMID: 27878683
    12. New molecular mechanisms of in vivo Multiple Myeloma (MM) growth and immunosuppression critically dependent on BCMA and APRIL in the Bone marrow microenvironment, further supporting targeting this prominent pathway in MM. PMID: 27127303
    13. Urinary APRIL (uAPRIL) and BAFF (uBAFF) levels were raised significantly in AN. PMID: 27804111
    14. High expression of APRIL is associated with hepatocellular carcinoma. PMID: 28035399
    15. Data did not detect any significant association with SNPs of APRIL, SPATA8, PDGFRA, and POLB with Systemic Lupus Erythematosus in Chinese Han Population. PMID: 27569236
    16. Recombinant human APRIL (rhAPRIL) could rescue HCC cell proliferation inhibited by miR-383. PMID: 26385772
    17. high expression of APRIL in clear cell renal cell carcinoma was correlated with high Fuhrman nuclear grade, high pathologic stage, and poor overall and cancer-specific survival of the patients PMID: 26296917
    18. TNFSF13 and FDX1 have potential roles in IgAN in the Han Chinese population. This information may be useful in the development of early prognostics for IgAN. PMID: 26431901
    19. Did not find any positive association between TNFSF13 SNPs and the risk of IgA nephropathy after adjustment for age and sex, but did find a significant and strong correlation with relevant clinical pathological parameters. PMID: 26370181
    20. plasma level elevated in IgA nephropathy PMID: 26986150
    21. results indicate that analysis of serum concentrations of BAFF and APRIL potentially represents a useful tool for the assessment of AIHA disease activity and progression. PMID: 26243624
    22. Abnormal levels of BAFF/APRIL in pediatric acute lymphoblastic leukemia suggest that BAFF/APRIL are associated with the development and progression of this disease in children PMID: 26950089
    23. SNPs rs9514828 (BAFF), rs3803800 (APRIL) and rs4985726 (TACI) may be associated with the risk of development of B-cell chronic lymphocytic leukemia in a Polish population. PMID: 26268376
    24. Data show decrease of serum APRIL levels in diabetic patients with Type-1 Diabetes or Type-2 Diabetes suggesting suggest that APRIL can be considered as a potential modulating cytokine in the inflammatory process of diabetes. PMID: 26469782
    25. Surface APRIL is elevated in circulating myeloid cells in patients with rheumatoid arthritis, where it is highly correlated with disease activity. PMID: 25729037
    26. elevated serum levels in patients with Behcet's disease PMID: 25759827
    27. the elevated presence of APRIL and BLyS in B cell-rich areas of chronically inflamed gingiva suggests that these cytokines may contribute to bone loss by promoting the survival and persistence of RANKL-expressing B cells/plasma cells. PMID: 26150532
    28. Results show that APRIL was significantly up-regulated in gastric cancer and high levels of APRIL correlated with resistance to cisplatin through the activation of the canonical NF-kappaB pathway. PMID: 25612651
    29. APRIL could be a potential diagnosed marker to distinguish glottic malignant disease from glottic benign lesion, and it may play an important role in the development of glottic malignant disease. PMID: 24276470
    30. APRIL expression is correlated with malignant gastrointestinal stromal tumours phenotypes and it may serve as an unfavourable prognostic marker in patients with gastrointestinal stromal tumours PMID: 25393252
    31. High APRIL expression is associated with breast cancer. PMID: 25750171
    32. Data suggest that APRIL protein (a proliferation-inducing ligand) could be a potential biomarker for predicting difficult-to-treat cases of lupus nephritis. PMID: 23171638
    33. APRIL is increased in patients with active systemic lupus erythematosus. PMID: 24748505
    34. Enhanced APRIL levels are associated with acute lymphoblastic leukemia. PMID: 25582383
    35. A high APRIL serum level was significantly associated with decreased progression-free survival in follicular lymphoma patients. PMID: 25146008
    36. APRIL may participate in the formation of seropositive rheumatoid arthritis. PMID: 24898359
    37. Our results suggest that an elevated level of BAFF/APRIL drives the maturation of B cells, subsequently leading to IgA2 class switching, and possibly to the development of interstitial lung disease in patients with mixed connective tissue disease. PMID: 24252051
    38. BAFF and APRIL as well as their cognate receptors (BCMA, TACI) correlate with glioma grade. (Meta-analysis) PMID: 24376672
    39. Show a novel method to obtain soluble human APRIL in Escherichia coli using the elastin-like polypeptide and SUMO (ELP-SUMO) tags. PMID: 24412409
    40. The levels of APRIL correlate with the progression of childhood ALL, which may provide certain clues for monitoring ALL clinically. PMID: 23887020
    41. Levels of serum APRIL are useful biomarkers for disease progression and disease activity in multiple myeloma. PMID: 24141333
    42. APRIL depletion induces cell cycle arrest and apoptosis partly through blocking noncanonical TGF-beta1/ERK. PMID: 23867993
    43. Increased serum expression of APRIL correlates with the development of colorectal neoplasms. PMID: 23792260
    44. Although neither serum BAFF nor APRIL correlated with disease activity in the overall population, elevated serum BAFF and reduced APRIL may be markers of renal and CNS disease in systemic lupus erythematosus patients PMID: 23846230
    45. Our findings indicate TNFSF13 is a prognostic factor in non-small cell lung cancer PMID: 24436270
    46. Both APRIL and B-cell-activating factor (BAFF) regulate spinal cord injury-induced autoimmunity through B-cell maturation antigen (BMCA). PMID: 23088438
    47. increased serum levels of BLyS and APRIL in BD patients supports the notion of a critical role for B cell activation factors in BD, particularly in terms of uveitis and disease activity. PMID: 22752534
    48. Using a capture sequencing strategy, we discovered the B-cell relevant genes IRF8, EBF1, and TNFSF13 as novel targets for IGH deregulation. PMID: 23775715
    49. APRIL protein is upregulated in the serum of patients with opsoclonus-myoclonus syndrome. PMID: 23324534
    50. High serum APRIL is associated with multiple myeloma. PMID: 23768867

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Secreted.
  • 蛋白家族：
    Tumor necrosis factor family
  • 組織特異性：
    Expressed at high levels in transformed cell lines, cancers of colon, thyroid, lymphoid tissues and specifically expressed in monocytes and macrophages.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 11928

    OMIM: 604472

    KEGG: hsa:8741

    STRING: 9606.ENSP00000343505

    UniGene: Hs.54673



×
生命科學(xué)計(jì)算平臺(tái)